Company Filing History:
Years Active: 2004-2011
Title: Innovator Jean-Bernard Le Pecq: Advancing Antibody Research
Introduction: Jean-Bernard Le Pecq is a notable inventor based in Menlo Park, California, with a commendable portfolio comprising three patents. His innovative work primarily focuses on methods and compounds related to antibody production and protein targeting to exosomes, significantly contributing to the fields of experimental and therapeutic research.
Latest Patents: Le Pecq’s recent patents address critical advancements in antibody research. One significant patent outlines the methods and compounds for raising antibodies and screening antibody repertoires. This invention details a process that involves the use of immunogenic vesicles with target antigens to invoke antigen-specific antibody responses. It also introduces methods for screening antibody repertoires, which includes isolating antibody-producing cells that exhibit defined antigen specificity.
Another influential patent by Le Pecq focuses on the targeting of proteins to exosomes. This invention presents compositions and methods for selectively expressing polypeptides in membrane vesicles. Moreover, it involves genetic constructs for recombinant cells capable of producing such vesicles, making it an essential tool in therapeutic and diagnostic contexts.
Career Highlights: Throughout his career, Jean-Bernard Le Pecq has made significant contributions to the realms of biotechnology and immunology. He has developed groundbreaking methodologies that enhance the ability to generate specific antibodies, thereby impacting research and clinical applications.
Collaborations: Collaboration has been a key element of Le Pecq’s success. He has worked alongside esteemed colleagues such as Alain Delcayre and Henry G. Lamparski, further enriching his innovative pursuits. Their collective expertise has likely fueled advancements in their shared projects, resulting in impactful innovations in antibody technology.
Conclusion: Jean-Bernard Le Pecq stands out as a leading inventor in the domain of antibody research. With his three patents, he has demonstrated a relentless commitment to innovation that benefits experimental, therapeutic, prophylactic, and diagnostic fields. His ongoing contributions continue to influence the ways in which antibodies are developed and utilized, paving the way for future breakthroughs in medical science.